Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2023-03-15Clinical Trial Update: Neural Mechanism of Aldosterone-induced Insulin Resistance [Phase 4]
A Phase 4 clinical trial investigating neural mechanisms of aldosterone-induced insulin resistance has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-02-21Clinical Trial Update: Effect of Eplerenone on Novel Biomarkers of Mineralocorticoid Receptor Activation (ENOVA) [Phase 4]
A Phase 4 trial evaluating the effect of eplerenone on novel biomarkers of mineralocorticoid receptor activation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2022-11-23Clinical Trial Update: A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease. [Phase 3]
Phase 3 trial of aprocitentan for uncontrolled blood pressure in chronic kidney disease was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2022-08-26Clinical Trial Update: Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes-----renal Substudy [Phase 4]
A Phase 4 clinical trial examining an intervention for high-normal blood pressure in adults with type 2 diabetes has been withdrawn.
-
EMA withdrawal · 2022-05-20EMA Withdrawn: Rasilez HCT (aliskiren;hydrochlorothiazide) — Noden Pharma DAC
The EMA has withdrawn Rasilez HCT (aliskiren; hydrochlorothiazide) from the market.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2021-09-17EMA Withdrawn: Telmisartan Teva (telmisartan) — Teva B.V.
Telmisartan Teva has been withdrawn from the European market.
-
CLINICAL_TRIALS withdrawal · 2021-02-24Clinical Trial Update: Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia. [Phase 3]
Phase 3 trial of a fixed-dose combination of valsartan and rosuvastatin was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-02-04Clinical Trial Update: Treating Nocturnal Hypertension and Nocturia in African American Men [Phase 4]
Phase 4 clinical trial investigating treatment of nocturnal hypertension and nocturia in African American men has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-09-03Clinical Trial Update: Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes [Phase 4]
Phase 4 study investigating losartan-based therapy in hypertensive patients, with and without diabetes, has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-01-14Clinical Trial Update: Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes. [Phase 4]
Phase 4 trial comparing ertugliflozin to hydrochlorothiazide for reducing sympathetic neural overactivity in patients with hypertension and …
-
CLINICAL_TRIALS withdrawal · 2019-08-14Clinical Trial Update: The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy [Phase 4]
Phase 4 trial of Cleviprex in ventriculostomy patients requiring IV antihypertensive therapy was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-07-05Clinical Trial Update: Targeting Microvascular Dysfunction in Young Hypertensive Patients [Phase 4]
A Phase 4 clinical trial targeting microvascular dysfunction in young hypertensive patients was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-02-19Clinical Trial Update: Combined Afib Ablation and RA Denervation for the Maintenance of Sinus Rhythm and Management of Resistant Hypertension [NA]
The clinical trial evaluating combined atrial fibrillation ablation and right atrial denervation for maintenance of sinus rhythm and managem…
-
CLINICAL_TRIALS withdrawal · 2019-02-11Clinical Trial Update: Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating potassium-magnesium citrate as a blood pressure–lowering agent in prehypertensive and hypertensive pat…
-
CLINICAL_TRIALS withdrawal · 2019-02-01Clinical Trial Update: Telemonitoring of Uncontrolled Hypertension [NA]
The Telemonitoring of Uncontrolled Hypertension trial sponsored by Universidad de la Republica has been withdrawn. The study concerns hypert…
-
CLINICAL_TRIALS withdrawal · 2018-03-07Clinical Trial Update: HIRREM for Pre-Hypertension [NA]
Clinical trial investigating HIRREM for prehypertension has been withdrawn (status: Withdrawn). No results are reported.
-
CLINICAL_TRIALS withdrawal · 2017-11-13Clinical Trial Update: Changes in Central Arterial Pressure When Comparing ACOG Hypertensive Urgency Protocols [NA]
A clinical trial evaluating changes in central arterial pressure under ACOG hypertensive urgency protocols has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-11-13Clinical Trial Update: Changes in Central Arterial Pressure When Comparing Nifedipine/Labetalol for Routine Hypertension Control in Pregnancy
The clinical trial evaluating changes in central arterial pressure when using nifedipine/labetalol to control hypertension in pregnancy has …
-
CLINICAL_TRIALS withdrawal · 2017-10-25Clinical Trial Update: Effect of Catheter-based Radiofrequency Ablation Therapy in Patient With Therapy-resistant Hypertension and Sleep Apnea Syndrome
The clinical trial investigating catheter-based radiofrequency ablation for therapy-resistant hypertension and sleep apnea was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-10-19Clinical Trial Update: Study of the Effect of Testosterone and Estradiol on NP Responses to Acute and Chronic Salt Loading [EARLY_Phase 1]
A Phase 1 study evaluating the effects of testosterone and estradiol on responses to acute and chronic salt loading in hypertension has been…
-
CLINICAL_TRIALS withdrawal · 2017-10-19Clinical Trial Update: Testosterone Regulation of the Natriuretic Peptide System [NA]
A clinical trial investigating testosterone regulation of the natriuretic peptide system for hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-10-02Clinical Trial Update: Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II Diabetics [Phase 4]
A Phase 4 trial evaluating aliskiren versus hydrochlorothiazide in hypertensive patients with type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-08-18Clinical Trial Update: EBMtrialcentral- Comparing Initial Diuretic Therapies Using a Collaborative Network [Phase 4]
A Phase 4 trial comparing initial diuretic therapies for hypertension, sponsored by Johns Hopkins University, has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-17Clinical Trial Update: The Effect of Clevidipine on Intracranial Pressure and Cerebral Perfusion Pressure (CCP) in Brain Injured Patients [Phase 4]
A Phase 4 trial evaluating clevidipine for effects on intracranial pressure and cerebral perfusion pressure in brain-injured patients has be…
-
CLINICAL_TRIALS withdrawal · 2017-07-12Clinical Trial Update: Evaluation of Lysine-Specific Demethylase 1 [NA]
A clinical trial evaluating Lysine-Specific Demethylase 1 for hypertension has been withdrawn.